Literature DB >> 26227479

Diagnostic yield of targeted next generation sequencing in various cancer types: an information-theoretic approach.

Ian S Hagemann1, Patrick K O'Neill2, Ivan Erill2, John D Pfeifer3.   

Abstract

The information-theoretic concept of Shannon entropy can be used to quantify the information provided by a diagnostic test. We hypothesized that in tumor types with stereotyped mutational profiles, the results of NGS testing would yield lower average information than in tumors with more diverse mutations. To test this hypothesis, we estimated the entropy of NGS testing in various cancer types, using results obtained from clinical sequencing. A set of 238 tumors were subjected to clinical targeted NGS across all exons of 27 genes. There were 120 actionable variants in 109 cases, occurring in the genes KRAS, EGFR, PTEN, PIK3CA, KIT, BRAF, NRAS, IDH1, and JAK2. Sequencing results for each tumor were modeled as a dichotomized genotype (actionable mutation detected or not detected) for each of the 27 genes. Based upon the entropy of these genotypes, sequencing was most informative for colorectal cancer (3.235 bits of information/case) followed by high grade glioma (2.938 bits), lung cancer (2.197 bits), pancreatic cancer (1.339 bits), and sarcoma/STTs (1.289 bits). In the most informative cancer types, the information content of NGS was similar to surgical pathology examination (modeled at approximately 2-3 bits). Entropy provides a novel measure of utility for laboratory testing in general and for NGS in particular. This metric is, however, purely analytical and does not capture the relative clinical significance of the identified variants, which may also differ across tumor types.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  comparative effectiveness research; high-throughput nucleotide sequencing; information theory; molecular diagnostic techniques; neoplasms

Mesh:

Year:  2015        PMID: 26227479     DOI: 10.1016/j.cancergen.2015.05.030

Source DB:  PubMed          Journal:  Cancer Genet


  5 in total

1.  Precision medicine: an opportunity for a paradigm shift in veterinary medicine.

Authors:  K C Kent Lloyd; Chand Khanna; William Hendricks; Jeffrey Trent; Michael Kotlikoff
Journal:  J Am Vet Med Assoc       Date:  2016-01-01       Impact factor: 1.936

Review 2.  Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.

Authors:  Catherine W Bennett; Guy Berchem; Yeoun Jin Kim; Victoria El-Khoury
Journal:  Oncotarget       Date:  2016-10-25

3.  Clinical Genotyping of Non-Small Cell Lung Cancers Using Targeted Next-Generation Sequencing: Utility of Identifying Rare and Co-mutations in Oncogenic Driver Genes.

Authors:  Laura J Tafe; Kirsten J Pierce; Jason D Peterson; Francine de Abreu; Vincent A Memoli; Candice C Black; Jason R Pettus; Jonathan D Marotti; Edward J Gutmann; Xiaoying Liu; Keisuke Shirai; Konstantin H Dragnev; Christopher I Amos; Gregory J Tsongalis
Journal:  Neoplasia       Date:  2016-09       Impact factor: 5.715

4.  Artificial Intelligence Approach for Variant Reporting.

Authors:  Michael G Zomnir; Lev Lipkin; Maciej Pacula; Enrique Dominguez Meneses; Allison MacLeay; Sekhar Duraisamy; Nishchal Nadhamuni; Saeed H Al Turki; Zongli Zheng; Miguel Rivera; Valentina Nardi; Dora Dias-Santagata; A John Iafrate; Long P Le; Jochen K Lennerz
Journal:  JCO Clin Cancer Inform       Date:  2018-03-22

Review 5.  Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy.

Authors:  Jun Lu; Baohui Han
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.